(Q36097041)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

title

Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

author name string

Longlong Luo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Shi Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Xiaoling Lang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Tingting Zhou

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Xinying Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Chunxia Qiao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Jiannan Feng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Beifen Shen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Ming Lv

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Yan Li

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

8 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

Cellular and Molecular Immunology

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

146-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

Potent antibody therapeutics by design

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Molecular engineering and design of therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Interactions of protein antigens with antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Anatomy of the antibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Integrating cell-level kinetic modeling into the design of engineered protein therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Humanization of an anti-human TNF-alpha antibody by variable region resurfacing with the aid of molecular modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

A novel TNFalpha antagonizing peptide-Fc fusion protein designed based on CDRs of TNFalpha neutralizing monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Affinity maturation of antiHER2 monoclonal antibody MIL5 using an epitope-specific synthetic phage library by computational design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Selecting and screening recombinant antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Development of a novel mammalian cell surface antibody display platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

The PD-1-PD-L pathway in immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Towards the design of an antibody that recognises a given protein epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1.

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5811676

Molecular events during maturation of the immune response to oxazolone

21 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FCMI.2016.38

IMGT/DomainGapAlign: IMGT standardized analysis of amino acid sequences of variable, constant, and groove domains (IG, TR, MH, IgSF, MhSF)

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/27499043

12 December 2020

A novel human scFv fragment against TNF-alpha from de novo design method

1 reference

https://pubmed.ncbi.nlm.nih.gov/27499043

12 December 2020

Analysis of antigenic surfaces of proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/27499043

12 December 2020

Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution

1 reference

https://pubmed.ncbi.nlm.nih.gov/27499043

12 December 2020

On the nature of antibody combining sites: Unusual structural features that may confer on these sites an enhanced capacity for binding ligands

1 reference

https://pubmed.ncbi.nlm.nih.gov/27499043

12 December 2020

Identifiers

DOI

10.1038/CMI.2016.38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27499043%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

PubMed publication ID

27499043

1 reference